MARKET

PLUR

PLUR

PLURILOCK SEC INC
NASDAQ
0.7475
+0.0205
+2.82%
Closed 16:00 02/23 EST
OPEN
0.7050
PREV CLOSE
0.7270
HIGH
0.7900
LOW
0.6900
VOLUME
134.73K
TURNOVER
0
52 WEEK HIGH
1.110
52 WEEK LOW
0.4311
MARKET CAP
31.01M
P/E (TTM)
-1.2593
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PLUR last week (0212-0216)?
Weekly Report · 6d ago
Pluri Inc. Secures $10 Million Share Sale Deal with A.G.P.
TipRanks · 02/13 21:13
Weekly Report: what happened at PLUR last week (0205-0209)?
Weekly Report · 02/12 11:01
Weekly Report: what happened at PLUR last week (0129-0202)?
Weekly Report · 02/05 11:08
Weekly Report: what happened at PLUR last week (0122-0126)?
Weekly Report · 01/29 10:58
PLURILOCK SEC INC: Statement of changes in beneficial ownership of securities
Press release · 01/25 23:11
Pluri Inc. Launches Sustainable Cell-Based Coffee Division
Pluri Inc. Has announced the launch of a cell-based coffee business under its new division, PluriAgtech. New venture aims to meet the increasing demand for sustainable, high-quality coffee produced on a mass scale. PLUR stock is down 2.7% in the last week.
TipRanks · 01/25 09:03
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Kura Oncology stock rose 39.6% to $18.73 during Wednesday's pre-market session. Redhill Biopharma (NASDAQ:RDHL) shares moved upwards by 24.51%. Akanda stock increased by 17.33% during the session. Losers AquaBounty Techs and vTVT stock decreased by 16.5%.
Benzinga · 01/24 13:05
More
About PLUR
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

Webull offers Pluri Inc stock information, including NASDAQ: PLUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLUR stock methods without spending real money on the virtual paper trading platform.